These benefits, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the principle of focusing on ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-similar disorders. Conolidine promises to get a https://napoleone024faw2.wikitron.com/user